Abstract
The development of imaging probes based on advances in nanotechnology aims to substantially improve specificity and sensitivity of diagnostic imaging through non-invasive and quantitative detection of specific biomolecules in living subjects. A promising class of molecular imaging probes consists of nanoparticles (NPs) functionalized with a certain targeting agent. Such targeting agents can, for instance, be selected to recognize disease-related biomarkers located on the cell surface. Among the possible agents that direct the NPs to the target site, aptamers, being single-stranded DNA or RNA molecules that can be designed to bind preselected targets such as proteins and peptides with high affinity and specificity, play an increasingly important role. Indeed, aptamers selected against proteins or whole cells have been conjugated to a variety of nanomaterials (NMs) such as Au NPs, quantum dots (QD), and superparamagnetic iron oxide NPs (SPIONs). These probes have successfully been used for cell imaging, both in vitro and in vivo, by optical imaging, magnetic resonance imaging (MRI), computed tomography (CT), and positron-emission tomography (PET). This review presents an overview of the commonly used techniques involved in conjugating aptamer to NPs and their application as probes in cellular or in vivo imaging.
Keywords: Aptamer, aptamer-conjugated nanoparticles, conjugation, medical imaging, diagnosis, nanoparticles
Current Topics in Medicinal Chemistry
Title:Conjugation Approaches for Construction of Aptamer-Modified Nanoparticles for Application in Imaging
Volume: 13 Issue: 4
Author(s): Jung Hwan Lee
Affiliation:
Keywords: Aptamer, aptamer-conjugated nanoparticles, conjugation, medical imaging, diagnosis, nanoparticles
Abstract: The development of imaging probes based on advances in nanotechnology aims to substantially improve specificity and sensitivity of diagnostic imaging through non-invasive and quantitative detection of specific biomolecules in living subjects. A promising class of molecular imaging probes consists of nanoparticles (NPs) functionalized with a certain targeting agent. Such targeting agents can, for instance, be selected to recognize disease-related biomarkers located on the cell surface. Among the possible agents that direct the NPs to the target site, aptamers, being single-stranded DNA or RNA molecules that can be designed to bind preselected targets such as proteins and peptides with high affinity and specificity, play an increasingly important role. Indeed, aptamers selected against proteins or whole cells have been conjugated to a variety of nanomaterials (NMs) such as Au NPs, quantum dots (QD), and superparamagnetic iron oxide NPs (SPIONs). These probes have successfully been used for cell imaging, both in vitro and in vivo, by optical imaging, magnetic resonance imaging (MRI), computed tomography (CT), and positron-emission tomography (PET). This review presents an overview of the commonly used techniques involved in conjugating aptamer to NPs and their application as probes in cellular or in vivo imaging.
Export Options
About this article
Cite this article as:
Lee Jung Hwan, Conjugation Approaches for Construction of Aptamer-Modified Nanoparticles for Application in Imaging, Current Topics in Medicinal Chemistry 2013; 13 (4) . https://dx.doi.org/10.2174/1568026611313040010
DOI https://dx.doi.org/10.2174/1568026611313040010 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment
Current Pharmaceutical Design Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
Current Pharmaceutical Design HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Tumors with Small Molecule Peptides
Current Cancer Drug Targets Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin
Recent Patents on Anti-Cancer Drug Discovery Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis
Current Genomics Nanoplatforms for Delivery of siRNA to the Eye
Current Pharmaceutical Design Aminophosphonate Metal Complexes of Biomedical Potential
Current Medicinal Chemistry Idronoxil as an Anticancer Agent: Activity and Mechanisms
Current Cancer Drug Targets Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
Current Signal Transduction Therapy Benzamides as Melanotropic Carriers for Radioisotopes, Metals, Cytotoxic Agents and as Enzyme Inhibitors
Current Medicinal Chemistry Molecular Aspects of FKBP51 that Enable Melanoma Dissemination
Current Molecular Pharmacology Tritiated Opioid Receptor Ligands as Radiotracers
Current Pharmaceutical Design Production of Alpha Emitters for Targeted Alpha Therapy
Current Radiopharmaceuticals CCL21 and IFNγ Recruit and Activate Tumor Specific T cells in 3D Scaffold Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Enhanced Pro-Apoptotic Effect of Tetrandrine Loaded Nanoparticles Against Osteosarcoma Cells
Current Drug Delivery Folate Targeted Solid Lipid Nanoparticles of Simvastatin for Enhanced Cytotoxic Effects of Doxorubicin in Chronic Myeloid Leukemia
Current Nanoscience Antigenic Differences Between Normal and Malignant Cells as a Basis for Treatment of Intracerebral Neoplasms Using a DNA-Based Vaccine
Current Genomics The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
Current Cancer Drug Targets